We are a global frontrunner in making oral vaccines a reality. We’ve created a proprietary Platform Technology using organic plants to manufacture Vaccines and Biologic Drugs. We have proven the Platform Technology through several grants from U.S. National Institutes of Health R&D, by a successful double-blind, placebo-controlled human clinical trial, and by endorsement of the U.S. Food and Drug Administration’s authorization of a second clinical trial on our very first vaccine.
New Platform Technology for organic production of pharmaceuticals.
With our Platform, green plants are used to manufacture complex biological drugs.
We have the ability to transform vaccines and certain biologic drugs from needle delivery to oral delivery using plants.
Humanitarian vaccination efforts worldwide are enhanced by being able to administer shelf-stable, oral vaccines without the need for a cold-chain environment and a needle.
With our proprietary Platform we can economically produce pure biologic drugs and vaccines using plants resulting in lower costs of biopharmaceuticals in the future.